Literature DB >> 24552422

Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping.

Donatella Caserta1, Gloria Adducchio, Simona Picchia, Eleonora Ralli, Eleonora Matteucci, Massimo Moscarini.   

Abstract

Metabolic syndrome is an increasing pathology in adults and in children, due to a parallel rise of obesity. Sedentary lifestyle, food habits, cultural influences and also a genetic predisposition can cause dyslipidemia, hypertension, abdominal obesity and insulin resistance which are the two main features of metabolic syndrome. Polycystic ovary syndrome (PCOS) is a condition directly associated with obesity, insulin resistance (HOMA index) and metabolic syndrome, and it is very interesting for its relationship and overlap with the metabolic syndrome. The relationship between the two syndromes is mutual: PCOS women have a higher prevalence of metabolic syndrome and also women with metabolic syndrome commonly present the reproductive/endocrine trait of PCOS. Prevention and treatment of metabolic syndrome and PCOS are similar for various aspects. It is necessary to treat excess adiposity and insulin resistance, with the overall goals of preventing cardiovascular disease and type 2 diabetes and improving reproductive failure in young women with PCOS. First of all, lifestyle changes, then pharmacological therapy, bariatric surgery and laparoscopic ovarian surgery represent the pillars for PCOS treatment.

Entities:  

Keywords:  BMI; HOMA; PCOS; lifestyle; metabolic syndrome; therapy

Mesh:

Year:  2014        PMID: 24552422     DOI: 10.3109/09513590.2014.887673

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  6 in total

Review 1.  Targets to treat metabolic syndrome in polycystic ovary syndrome.

Authors:  Shruthi Mahalingaiah; Evanthia Diamanti-Kandarakis
Journal:  Expert Opin Ther Targets       Date:  2015-10-21       Impact factor: 6.902

2.  History of infertility and risk of type 2 diabetes mellitus: a prospective cohort study.

Authors:  Deirdre K Tobias; Audrey J Gaskins; Stacey A Missmer; Frank B Hu; JoAnn E Manson; Germaine M Buck Louis; Cuilin Zhang; Jorge E Chavarro
Journal:  Diabetologia       Date:  2015-01-18       Impact factor: 10.122

3.  Genetic variation in the Mcp-1 gene promoter associated with the risk of polycystic ovary syndrome.

Authors:  Lan Li; Ji Eun Ryoo; Kyung-Ju Lee; Bum-Chae Choi; Kwang-Hyun Baek
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

4.  A Rat Model of Maternal Polycystic Ovary Syndrome Shows that Exposure to Androgens In Utero Results in Dysbiosis of the Intestinal Microbiota and Metabolic Disorders of the Newborn Rat.

Authors:  Tuohetimulati Gulan; Tusufuhan Yeernuer; Shuang Sui; Niziya Mayinuer
Journal:  Med Sci Monit       Date:  2019-12-09

Review 5.  The Effects of Salvia miltiorrhiza on Reproduction and Metabolism in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Wenjuan Shen; Bao Jin; Yaguang Han; Hongwei Wang; Huan Jiang; Linlin Zhu; Mei Han; Jiao Zhang; Yang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-15       Impact factor: 2.629

6.  Circulating SCUBE1 levels in women with polycystic ovary syndrome.

Authors:  Onur Erol; Hamit Yaşar Ellidağ; Mustafa Kemal Özel; Aysel Uysal Derbent; Esin Eren; Necat Yılmaz
Journal:  Turk J Obstet Gynecol       Date:  2018-09-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.